Suven Pharmaceuticals consolidated net profit declines 49.61% in the June 2024 quarter
Net profit of Suven Pharmaceuticals declined 49.61% to Rs 60.77 crore in the quarter ended June 2024 as against Rs 120.59 crore during the previous quarter ended June 2023. Sales declined 33.62% to Rs 230.69 crore in the quarter ended June 2024 as against Rs 347.55 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 230.69 | 347.55 | -34 |
OPM % | 34.65 | 48.04 | - |
PBDT | 96.49 | 176.48 | -45 |
PBT | 83.09 | 163.94 | -49 |
NP | 60.77 | 120.59 | -50 |
What is the Bombay Stock Exchange?
10 mins read . Dec 9, 2024
Stocks Under 5 Rupees in India
13 mins read . Dec 9, 2024
Stocks Under 1000 Rupees in India
14 mins read . Dec 6, 2024
Explore our products
₹0 Brokerage *
Open Demat Account